Low molecular weight heparin clinical trials

Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk

This study looks at whether a blood-thinning medicine called LMWH can prevent dangerous blood clots in new mothers who have a medium risk of getting them after childbirth. It compares taking the medicine for 6 weeks to not taking it.